These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 9767466)
1. Rat NKR-P1+ CD3+ T cells: selective proliferation in interleukin-2, diverse T-cell-receptor-Vbeta repertoire and polarized interferon-gamma expression. Badovinac V; Boggiano C; Trajković V; Frey AB; Vujanović NL; Gold DP; Mostarica-Stojković M; Vukmanović S Immunology; 1998 Sep; 95(1):117-25. PubMed ID: 9767466 [TBL] [Abstract][Full Text] [Related]
2. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298 [TBL] [Abstract][Full Text] [Related]
3. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. Arase H; Arase N; Saito T J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351 [TBL] [Abstract][Full Text] [Related]
4. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. Koyasu S J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719 [TBL] [Abstract][Full Text] [Related]
5. IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Leite-De-Moraes MC; Moreau G; Arnould A; Machavoine F; Garcia C; Papiernik M; Dy M Eur J Immunol; 1998 May; 28(5):1507-15. PubMed ID: 9603455 [TBL] [Abstract][Full Text] [Related]
6. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. Iijima H; Takahashi I; Kishi D; Kim JK; Kawano S; Hori M; Kiyono H J Exp Med; 1999 Sep; 190(5):607-15. PubMed ID: 10477546 [TBL] [Abstract][Full Text] [Related]
7. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice. Pioli C; Pucci S; Barile S; Frasca D; Doria G Immunology; 1998 Jul; 94(3):380-7. PubMed ID: 9767421 [TBL] [Abstract][Full Text] [Related]
8. Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain. Krymskaya L; Lee WH; Zhong L; Liu CP J Immunol; 2005 Feb; 174(3):1188-95. PubMed ID: 15661872 [TBL] [Abstract][Full Text] [Related]
9. Massive production of Th2 cytokines by human CD4+ effector T cells transiently expressing the natural killer cell marker CD57/HNK1. Brinkmann V; Kristofic C Immunology; 1997 Aug; 91(4):541-7. PubMed ID: 9378492 [TBL] [Abstract][Full Text] [Related]
10. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Hoshino T; Yagita H; Ortaldo JR; Wiltrout RH; Young HA Eur J Immunol; 2000 Jul; 30(7):1998-2006. PubMed ID: 10940889 [TBL] [Abstract][Full Text] [Related]
11. DA rat NK(+)CD3(-) cells inhibit autoreactive T-cell responses. Wolf NA; Swanborg RH J Neuroimmunol; 2001 Sep; 119(1):81-7. PubMed ID: 11525803 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Smiley ST; Kaplan MH; Grusby MJ Science; 1997 Feb; 275(5302):977-9. PubMed ID: 9020080 [TBL] [Abstract][Full Text] [Related]
13. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Matsuda JL; Gapin L; Baron JL; Sidobre S; Stetson DB; Mohrs M; Locksley RM; Kronenberg M Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8395-400. PubMed ID: 12829795 [TBL] [Abstract][Full Text] [Related]
14. An atypical population of NK cells that spontaneously secrete IFN-gamma and IL-4 is present in the intraepithelial lymphoid compartment of the rat. Todd DJ; Greiner DL; Rossini AA; Mordes JP; Bortell R J Immunol; 2001 Oct; 167(7):3600-9. PubMed ID: 11564772 [TBL] [Abstract][Full Text] [Related]
15. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. Hosken NA; Shibuya K; Heath AW; Murphy KM; O'Garra A J Exp Med; 1995 Nov; 182(5):1579-84. PubMed ID: 7595228 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4+) T lymphocytes. Borger P; Kauffman HF; Postma DS; Esselink MT; Vellenga E Immunology; 1999 Feb; 96(2):207-14. PubMed ID: 10233697 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation. Lee EJ; Ko E; Lee J; Rho S; Ko S; Shin MK; Min BI; Hong MC; Kim SY; Bae H Int Immunopharmacol; 2004 Feb; 4(2):235-44. PubMed ID: 14996415 [TBL] [Abstract][Full Text] [Related]
18. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells. Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas. Metwali A; Blum A; Elliott DE; Weinstock JV Infect Immun; 2002 Oct; 70(10):5651-8. PubMed ID: 12228294 [TBL] [Abstract][Full Text] [Related]
20. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. Chen H; Paul WE J Immunol; 1997 Sep; 159(5):2240-9. PubMed ID: 9278312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]